These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 20647002)
1. Solution structure of the N-terminal transactivation domain of ERM modified by SUMO-1. Lens Z; Dewitte F; Monté D; Baert JL; Bompard C; Sénéchal M; Van Lint C; de Launoit Y; Villeret V; Verger A Biochem Biophys Res Commun; 2010 Aug; 399(1):104-10. PubMed ID: 20647002 [TBL] [Abstract][Full Text] [Related]
2. Two functionally distinct domains responsible for transactivation by the Ets family member ERM. Laget MP; Defossez PA; Albagli O; Baert JL; Dewitte F; Stehelin D; de Launoit Y Oncogene; 1996 Mar; 12(6):1325-36. PubMed ID: 8649835 [TBL] [Abstract][Full Text] [Related]
3. ERM transcription factor contains an inhibitory domain which functions in sumoylation-dependent manner. Degerny C; de Launoit Y; Baert JL Biochim Biophys Acta; 2008 Mar; 1779(3):183-94. PubMed ID: 18243147 [TBL] [Abstract][Full Text] [Related]
4. The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA. Janknecht R; Monté D; Baert JL; de Launoit Y Oncogene; 1996 Oct; 13(8):1745-54. PubMed ID: 8895521 [TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800 [TBL] [Abstract][Full Text] [Related]
6. The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylation. Bojović BB; Hassell JA DNA Cell Biol; 2008 Jun; 27(6):289-305. PubMed ID: 18447755 [TBL] [Abstract][Full Text] [Related]
7. A conditional version of the Ets transcription factor Erm by fusion to the ligand binding domain of the oestrogen receptor. Pelczar H; Albagli O; Chotteau-Lelievre A; Damour I; de Launoit Y Biochem Biophys Res Commun; 1997 Oct; 239(1):252-6. PubMed ID: 9345304 [TBL] [Abstract][Full Text] [Related]
8. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP). Chang CH; Scott GK; Baldwin MA; Benz CC Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676 [TBL] [Abstract][Full Text] [Related]
9. SUMO down-regulates the activity of Elf4/myeloid Elf-1-like factor. Suico MA; Nakamura H; Lu Z; Saitoh H; Shuto T; Nakao M; Kai H Biochem Biophys Res Commun; 2006 Sep; 348(3):880-8. PubMed ID: 16904644 [TBL] [Abstract][Full Text] [Related]
10. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382 [TBL] [Abstract][Full Text] [Related]
11. SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity. Degerny C; Monte D; Beaudoin C; Jaffray E; Portois L; Hay RT; de Launoit Y; Baert JL J Biol Chem; 2005 Jul; 280(26):24330-8. PubMed ID: 15857832 [TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Brunet Simioni M; De Thonel A; Hammann A; Joly AL; Bossis G; Fourmaux E; Bouchot A; Landry J; Piechaczyk M; Garrido C Oncogene; 2009 Sep; 28(37):3332-44. PubMed ID: 19597476 [TBL] [Abstract][Full Text] [Related]
13. The intrinsically unstructured domain of PC4 modulates the activity of the structured core through inter- and intramolecular interactions. Jonker HR; Wechselberger RW; Boelens R; Kaptein R; Folkers GE Biochemistry; 2006 Apr; 45(15):5067-81. PubMed ID: 16605275 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human. Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226 [TBL] [Abstract][Full Text] [Related]
16. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity. Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340 [TBL] [Abstract][Full Text] [Related]
17. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Ledl A; Schmidt D; Müller S Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA binding of Sox2 by the SUMO conjugation. Tsuruzoe S; Ishihara K; Uchimura Y; Watanabe S; Sekita Y; Aoto T; Saitoh H; Yuasa Y; Niwa H; Kawasuji M; Baba H; Nakao M Biochem Biophys Res Commun; 2006 Dec; 351(4):920-6. PubMed ID: 17097055 [TBL] [Abstract][Full Text] [Related]
19. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Tian S; Poukka H; Palvimo JJ; Jänne OA Biochem J; 2002 Nov; 367(Pt 3):907-11. PubMed ID: 12144530 [TBL] [Abstract][Full Text] [Related]
20. Quaternary structure of flavorubredoxin as revealed by synchrotron radiation small-angle X-ray scattering. Petoukhov MV; Vicente JB; Crowley PB; Carrondo MA; Teixeira M; Svergun DI Structure; 2008 Sep; 16(9):1428-36. PubMed ID: 18786405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]